China Pharma Holdings (CPHI) EPS (Weighted Average and Diluted) (2010 - 2026)
China Pharma Holdings (CPHI) reported EPS (Weighted Average and Diluted) of -$0.04 for Q1 2026, up 83.33% on a YoY basis from -$0.02 in Q1 2025, and up 76.47% quarter-over-quarter from -$0.17 in Q4 2025.
China Pharma Holdings (CPHI) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported EPS (Weighted Average and Diluted) for 11 years, with the latest figure at -$0.04 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 83.33% year-over-year to -$0.04; the trailing twelve-month figure through Mar 2026 stood at -$0.54 (up 75.89% YoY), and the FY2025 full-year result was -$0.74, up 72.69% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.04, up from -$0.17 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.02 in Q4 2023, with the low at -$0.89 in Q2 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.35 across 4 years, with a median of -$0.24 in 2025.
- Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) plunged 2200.0% — and 2026, when it soared 83.33%.
- China Pharma Holdings' EPS (Weighted Average and Diluted) stood at -$0.02 in 2023, then sank by 2200.0% to -$0.46 in 2024, then surged by 63.04% to -$0.17 in 2025, then surged by 76.47% to -$0.04 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.04 (Q1 2026), -$0.17 (Q4 2025), and -$0.17 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.17 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.16 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.46 |
| Sep 30, 2024 | -0.65 |
| Jun 30, 2024 | -0.89 |
| Mar 31, 2024 | -0.72 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | -0.29 |
| Sep 30, 2016 | -0.04 |
| Jun 30, 2016 | -0.06 |
| Mar 31, 2016 | -0.04 |
| Dec 31, 2015 | -0.14 |
| Sep 30, 2015 | 0.07 |
| Jun 30, 2015 | 0.03 |
| Mar 31, 2015 | -0.09 |
| Dec 31, 2014 | -0.51 |
| Sep 30, 2014 | -0.15 |